Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. (Q38243695)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Toshi A Furukawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Yusuke Ogawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Aran Tajika

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Nozomi Takeshima

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Yu Hayasaka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

1 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

number of pages

15

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

989-1003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Health care utilization and costs among patients treated for bipolar disorder in an insured population.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

The treatment of mixed states and the risk of switching to depression

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Clinical practice recommendations for bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Olanzapine versus divalproex in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Imputing response rates from means and standard deviations in meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0197-8

21 January 2018

Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/25160685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/25160685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25160685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25160685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute mania: haloperidol dose and augmentation with lithium or lorazepam

1 reference

https://pubmed.ncbi.nlm.nih.gov/25160685

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40263-014-0197-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25160685%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38243695&oldid=2201460282"